News
Product launch: Pig NGAL ELISA Kit (KIT 044)
August 16 2010
BioPorto’s NGAL test approved for use by leading U.S. reference laboratory
August 12 2010
AACC/Clinical Lab Expo 2010, July 27-29, Anaheim, CA
July 06 2010
IUTOX 2010, July 19-23, Barcelona, Spain
June 30 2010
BioPorto Diagnostics at the ERA-EDTA Congress, Munich, June 25-28
June 14 2010
BioPorto Diagnostics at APCN 2010, June 5-8, Seoul, Korea
May 21 2010
Presentation of The NGAL Test data at the BRS/RA Conference, May 17-20, Manchester, UK
May 14 2010
Presentation of The NGAL Test data at the 30th International Symposium on Intensive Care and Emergency Medicine (ISICEM)
February 22 2010
TSIS 2010, March 9-13, Munich, Germany
February 18 2010
ToxExpo, March 7-11, Salt Lake City, Utah
February 16 2010
CRITICARE 2010, February 10-14, Hyderabad, India
January 25 2010 by Ana Belén Enfedaque Buisán
BioPorto Diagnostics will be exhibiting at the upcoming International Critical Care Congress of the Indian Society of Critical Care Medicine (ISCCM). The exhibition will be a joint venture with CPC Diagnostics, BioPorto’s exclusive distributor in South and East India.
Aimed at strengthing the existing bond between industry and the physician community and exploring means to provide affordable medical care to deserving patients, CRITICARE 2010 is one of the most important events on the calendar of every critical care practitioner in India. Around 3,000 Intensivists, Physicians, Pulmonologist, Paediatricians and Anaesthesiologist delegates from India and neighboring countries are expected to take part in this congress.
At the congress, BioPorto Diagnostics will promote their proprietary biomarkers - NGAL for AKI diagnosis and APC-PCI for sepsis.
Trine Østerbye, Sales and Marketing Manager toe@bioporto.com and Ishan Gupta, Business Development Manager, Sales ig@bioporto.com will represent BioPorto Diagnostics. Visit us at booth 34-35 in the Hyderabad International Convention Center.
For further information on CRITICARE 2010: http://criticare2010.org/
